Narrative review of the effects of antidiabetic drugs on albuminuria

Habib Yaribeygi, Stephen Atkin, Niki Katsiki, Amirhossein Sahebkar

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Diabetes mellitus is the most prevalent metabolic disorder worldwide. Glycemic control is the main focus of antidiabetic therapy. However, there are data suggesting that some antidiabetic drugs may have intrinsic beneficial renal effects and protect against the development and progression of albuminuria, thus minimizing the risk of diabetic nephropathy. These pharmacological agents can suppress upstream molecular pathways involved in the pathophysiology of diabetes-induced renal dysfunction such as oxidative stress, inflammatory responses, and apoptosis. In this narrative review, the pathophysiology of albuminuria in patients with diabetic nephropathy is discussed. Furthermore, the renoprotective effects of antidiabetic drugs, focusing on albuminuria, are reviewed.

Original languageEnglish
JournalJournal of Cellular Physiology
DOIs
Publication statusAccepted/In press - 1 Jan 2018

Fingerprint

Albuminuria
Hypoglycemic Agents
Diabetic Nephropathies
Medical problems
Kidney
Oxidative stress
Diabetes Mellitus
Oxidative Stress
Pharmacology
Apoptosis
Therapeutics

Keywords

  • antidiabetic agents
  • diabetes mellitus
  • diabetic nephropathy
  • oxidative stress
  • renal dysfunction

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Narrative review of the effects of antidiabetic drugs on albuminuria. / Yaribeygi, Habib; Atkin, Stephen; Katsiki, Niki; Sahebkar, Amirhossein.

In: Journal of Cellular Physiology, 01.01.2018.

Research output: Contribution to journalArticle

@article{61e36feb693a47e59722946255b52d30,
title = "Narrative review of the effects of antidiabetic drugs on albuminuria",
abstract = "Diabetes mellitus is the most prevalent metabolic disorder worldwide. Glycemic control is the main focus of antidiabetic therapy. However, there are data suggesting that some antidiabetic drugs may have intrinsic beneficial renal effects and protect against the development and progression of albuminuria, thus minimizing the risk of diabetic nephropathy. These pharmacological agents can suppress upstream molecular pathways involved in the pathophysiology of diabetes-induced renal dysfunction such as oxidative stress, inflammatory responses, and apoptosis. In this narrative review, the pathophysiology of albuminuria in patients with diabetic nephropathy is discussed. Furthermore, the renoprotective effects of antidiabetic drugs, focusing on albuminuria, are reviewed.",
keywords = "antidiabetic agents, diabetes mellitus, diabetic nephropathy, oxidative stress, renal dysfunction",
author = "Habib Yaribeygi and Stephen Atkin and Niki Katsiki and Amirhossein Sahebkar",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/jcp.27503",
language = "English",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Narrative review of the effects of antidiabetic drugs on albuminuria

AU - Yaribeygi, Habib

AU - Atkin, Stephen

AU - Katsiki, Niki

AU - Sahebkar, Amirhossein

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Diabetes mellitus is the most prevalent metabolic disorder worldwide. Glycemic control is the main focus of antidiabetic therapy. However, there are data suggesting that some antidiabetic drugs may have intrinsic beneficial renal effects and protect against the development and progression of albuminuria, thus minimizing the risk of diabetic nephropathy. These pharmacological agents can suppress upstream molecular pathways involved in the pathophysiology of diabetes-induced renal dysfunction such as oxidative stress, inflammatory responses, and apoptosis. In this narrative review, the pathophysiology of albuminuria in patients with diabetic nephropathy is discussed. Furthermore, the renoprotective effects of antidiabetic drugs, focusing on albuminuria, are reviewed.

AB - Diabetes mellitus is the most prevalent metabolic disorder worldwide. Glycemic control is the main focus of antidiabetic therapy. However, there are data suggesting that some antidiabetic drugs may have intrinsic beneficial renal effects and protect against the development and progression of albuminuria, thus minimizing the risk of diabetic nephropathy. These pharmacological agents can suppress upstream molecular pathways involved in the pathophysiology of diabetes-induced renal dysfunction such as oxidative stress, inflammatory responses, and apoptosis. In this narrative review, the pathophysiology of albuminuria in patients with diabetic nephropathy is discussed. Furthermore, the renoprotective effects of antidiabetic drugs, focusing on albuminuria, are reviewed.

KW - antidiabetic agents

KW - diabetes mellitus

KW - diabetic nephropathy

KW - oxidative stress

KW - renal dysfunction

UR - http://www.scopus.com/inward/record.url?scp=85055746758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055746758&partnerID=8YFLogxK

U2 - 10.1002/jcp.27503

DO - 10.1002/jcp.27503

M3 - Article

C2 - 30367464

AN - SCOPUS:85055746758

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

ER -